Anavex Life Sciences
AVXL
AVXL
144 hedge funds and large institutions have $153M invested in Anavex Life Sciences in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% more call options, than puts
Call options by funds: $4.89M | Put options by funds: $4.79M
0.13% more ownership
Funds ownership: 31.67% → 31.8% (+0.13%)
Holders
144
Holding in Top 10
–
Calls
$4.89M
Puts
$4.79M
Top Buyers
| 1 | +$5.17M | |
| 2 | +$1.98M | |
| 3 | +$1.72M | |
| 4 |
Morgan Stanley
New York
|
+$1.59M |
| 5 |
Goldman Sachs
New York
|
+$1.16M |
Top Sellers
| 1 | -$3.83M | |
| 2 | -$2.39M | |
| 3 | -$1.85M | |
| 4 |
Renaissance Technologies
New York
|
-$1.26M |
| 5 |
Two Sigma Investments
New York
|
-$1.04M |